Drug
Bupivacaine Liposome Injectable
Bupivacaine Liposome Injectable: highest development phase Post-Market, developed by Heron Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Heron Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bupivacaine liposome injectable suspension NCT04102267 | Post-Market | Analgesia |
Latest
No recent events.
Follow Bupivacaine Liposome Injectable on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.